NMTC (NeuroOne Medical Technologies) Cyclically Adjusted Book per Share: $-1.49 (As of Mar. 2026)


NMTC NeuroOne Medical Technologies Corp NMTC
39 GF Score
Price $3.00
GF Value $6.60
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies Cyclically Adjusted Book per Share?

NeuroOne Medical Technologies NMTC -0.66% 39 Cyclically Adjusted Book per Share is $-1.49 as of Mar. 2026. GuruFocus rates NMTC with a GF Score™ of 39/100 and a GF Value™ of $6.60 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

NeuroOne Medical Technologies's adjusted book value per share for the three months ended in Mar. 2026 was $0.624. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-1.49 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of NeuroOne Medical Technologies was 12.20% per year. The lowest was 4.60% per year. And the median was 8.90% per year.

As of today (2026-07-02), NeuroOne Medical Technologies's current stock price is $3.00. NeuroOne Medical Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $-1.49. NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio of today is .


NeuroOne Medical Technologies  (NAS:NMTC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


NeuroOne Medical Technologies Cyclically Adjusted Book per Share Related Terms


NeuroOne Medical Technologies Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for NeuroOne Medical Technologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuroOne Medical Technologies Cyclically Adjusted Book per Share Chart

NeuroOne Medical Technologies Annual Data
Trend Dec16 Dec17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.06 -1.75 -1.60 -1.56 -1.52

NeuroOne Medical Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.56 -1.54 -1.52 -1.49 -1.49

NMTC vs RDGL, TANAF, MODD: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeuroOne Medical Technologies Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's Cyclically Adjusted PB Ratio falls into.


NMTC
39GF Score
NeuroOne Medical Technologies Corp NMTC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroOne Medical Technologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeuroOne Medical Technologies's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.624/330.2130*330.2130
=0.624

Current CPI (Mar. 2026) = 330.2130.

NeuroOne Medical Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.355 241.018 -0.486
201609 -0.372 241.428 -0.509
201612 -0.943 241.432 -1.290
201703 -0.372 243.801 -0.504
201706 -0.454 244.955 -0.612
201709 -8.076 246.819 -10.805
201712 -11.526 246.524 -15.439
201803 -14.634 249.554 -19.364
201806 -16.380 251.989 -21.465
201809 -8.201 252.439 -10.728
201812 -8.885 251.233 -11.678
201903 0.619 254.202 0.804
201906 -0.366 256.143 -0.472
201909 -1.651 256.759 -2.123
201912 -6.045 256.974 -7.768
202003 -6.656 258.115 -8.515
202006 -3.877 257.797 -4.966
202009 1.677 260.280 2.128
202012 1.097 260.474 1.391
202103 5.471 264.877 6.821
202106 4.434 271.696 5.389
202109 3.274 274.310 3.941
202112 5.911 278.802 7.001
202203 4.862 287.504 5.584
202206 3.934 296.311 4.384
202209 3.553 296.808 3.953
202212 3.020 296.797 3.360
202303 1.966 301.836 2.151
202306 1.317 305.109 1.425
202309 1.567 307.789 1.681
202312 1.067 306.746 1.149
202403 0.879 312.332 0.929
202406 0.649 314.175 0.682
202409 0.160 315.301 0.168
202412 0.571 315.605 0.597
202503 0.215 319.799 0.222
202506 0.985 322.561 1.008
202509 0.849 324.800 0.863
202512 0.762 324.054 0.776
202603 0.624 330.213 0.624

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-1.49 mean?
NeuroOne Medical Technologies (NMTC) has a Cyclically Adjusted Book per Share of $-1.49 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NeuroOne Medical Technologies and its competitors.
Is NeuroOne Medical Technologies' Cyclically Adjusted Book per Share too high?
NeuroOne Medical Technologies' current Cyclically Adjusted Book per Share is $-1.49. Overall, NeuroOne Medical Technologies has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NeuroOne Medical Technologies' Cyclically Adjusted Book per Share compare to RDGL and TANAF?
NeuroOne Medical Technologies' Cyclically Adjusted Book per Share of $-1.49 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on NeuroOne Medical Technologies and its competitors. NeuroOne Medical Technologies's current Cyclically Adjusted Book per Share is $-1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroOne Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, NeuroOne Medical Technologies (NMTC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.60, compared to a current price of $3.00 — trading 54.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is $-1.49. NeuroOne Medical Technologies' overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For NeuroOne Medical Technologies (NMTC), the current Cyclically Adjusted Book per Share is $-1.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeuroOne Medical Technologies (NMTC) Overvalued in 2026?

Based on GuruFocus' analysis, NeuroOne Medical Technologies stock appears to be undervalued. The current stock price of $3.00 is trading 54.5% below its estimated GF Value™ of $6.60. GuruFocus considers NeuroOne Medical Technologies to be Possible Value Trap.

Key valuation signals for NMTC:

  • Cyclically Adjusted Book per Share: $-1.49
  • GF Value™: $6.60 vs. price of $3.00 (54.5% below fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the NMTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
39GF Score

Get the complete analysis for NMTC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.00
Price
$6.60
GF Value